Pre‐ and postischemic pulsed acoustic cellular expression conditioning modulates expression of inflammation factors in cremaster ischemia/reperfusion injury model
Authors:
- Joanna M. CwykielJCJoanna M. Cwykiel
- Aleksandra KlimczakAleksandra Klimczak
- Lukasz KrokowiczLKLukasz Krokowicz
- Maria SiemionowMSMaria Siemionow
- 14 November 2012
- journal article
- research article
- Published by Wiley in Microsurgery
- Vol. 33 (2) , 134-140
Abstract
Pulsed acoustic cellular expression (PACE) is a treatment that applies focused acoustic shock waves to promote tissue healing. The aim of this study was to assess the effect of PACE treatment on inflammatory responses in a cremaster muscle ischemia/reperfusion injury model. Seventeen cremaster muscle flaps were evaluated in four groups: nonischemic controls (n = 5), 5‐hour ischemia controls (n = 4), preischemic (5‐hour) PACE conditioning (n = 4), and postischemic (5‐hour) PACE conditioning (n = 4). The expression of proinflammatory cytokines (TNFα, IL‐6, IL‐1α, IL‐1β, GM‐CSF) and chemokines (CCL3, CCL4, CXCL4) was assessed using TaqMan® real‐time PCR. Expression of ELAM‐1, VCAM‐1, and ICAM‐1 was assessed by immunostaining. Preischemic PACE conditioning upregulated expression of IL‐6, CCL3, CCL4, and CXCL4, and downregulated expression of TNFα, GM‐CSF, and IL‐1α. Postischemic PACE conditioning significantly decreased expression of all evaluated genes. Pre‐ and postischemic PACE conditioning decreased expression of ELAM‐1 and ICAM‐1. Results of the study indicate that application of PACE conditioning may have a beneficial effect on the recovery of tissues subjected to the ischemia/reperfusion injury. Postischemic PACE conditioning revealed anti‐inflammatory effect as confirmed by decreased expression of inflammatory cytokines, chemokines, and cell adhesion molecules (ELAM‐1 and ICAM‐1) that are responsible for leukocyte recruitment into ischemic tissues. Hence, PACE therapy may be used effectively in clinical practice as a convenient therapeutic strategy to protect tissues against ischemia/reperfusion related injury after microsurgical procedures of free tissue transfers. © 2012 Wiley Periodicals, Inc. Microsurgery, 2013.Keywords
Funding Information
- SanuWave Inc., Alpharetta, Atlanta, GA, USA
This publication has 24 references indexed in Scilit:
- Extracorporeal shockwave therapy in musculoskeletal disordersJournal of Orthopaedic Surgery and Research, 2012
- Optimal Timing of Extracorporeal Shock Wave Treatment to Protect Ischemic TissueAnnals of Plastic Surgery, 2011
- Is the knowledge on tissue microcirculation important for microsurgeon?Microsurgery, 2011
- Pulsed Acoustic Cellular Treatment Induces Expression of Proangiogenic Factors and Chemokines in Muscle FlapsJournal of Trauma: Injury, Infection & Critical Care, 2010
- The management of neuropathic ulcers of the foot in diabetes by shock wave therapyBMC Musculoskeletal Disorders, 2009
- Extracorporeal shock wave therapy suppresses the early proinflammatory immune response to a severe cutaneous burn injury*International Wound Journal, 2009
- Modulation of Oxidant and Antioxidant Enzyme Expression and Function in Vascular CellsHypertension, 2004
- β-chemokine function in experimental lung ischemia-reperfusion injuryThe Annals of Thoracic Surgery, 2004
- Why does inflammation persist: a dominant role for the stromal microenvironment?Expert Reviews in Molecular Medicine, 2002
- Vascular isolation of the rat cremaster muscleMicrovascular Research, 1988